SAN JOSE, Calif., May 22 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. , a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the FBR Capital Markets 12th Annual Spring Investor Conference, to be held May 28-29, 2008, at the Grand Hyatt New York in New York, NY.
VNUS’ presentation is currently scheduled for 12:50 p.m. ET on Thursday, May 29, and will be webcast on the corporate website at http://ir.vnus.com/events.cfm. The management speakers will be Brian Farley, President and Chief Executive Officer, and Peter Osborne, Chief Financial Officer and Vice President of Finance and Administration.
About VNUS Medical Technologies, Inc.
VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of painful varicose veins. VNUS sells the Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. Approximately 300,000 patients have been treated to date with VNUS Closure catheters. For more information, please visit the corporate website at http://www.vnus.com.
CONTACT: Peter Osborne, Chief Financial Officer and Vice President of
Finance and Administration of VNUS Medical Technologies, Inc.,
+1-408-360-7499, ir@vnus.com
Web site: http://www.vnus.com/
http://ir.vnus.com/events.cfm/
